Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 68
Selected: 0
NCT IDTitle
NCT01534546Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
NCT00166543Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
NCT02562807A Study of TAS-303 in Female Patients With Stress Urinary Incontinence
NCT01811277SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer
NCT00077142TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
NCT02261532A Phase I Study of TAS-102 in Solid Tumors
NCT01227239Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
NCT04683250Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
NCT01955837Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia
NCT02602327Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
NCT00569790Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer
NCT04923529TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma
NCT00429858Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
NCT00824161Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer
NCT02322593Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
NCT05335499A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria
NCT01824459S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
NCT00569699Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
NCT00152191A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
NCT05568095A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
NCT00639327Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
NCT00284258Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
NCT04920032Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
NCT00202969Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
NCT00498225Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
NCT04825431Mass Balance Study of [14C] TAS-205 in Healthy Volunteers
NCT02024841Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis
NCT02128243Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
NCT02246478A Study of TAS-205 for Duchenne Muscular Dystrophy
NCT00661167Phase II Study of ABI-007 for Gastric Cancer
NCT00152243A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
NCT00142350A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
NCT03605251Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.
NCT01679340A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
NCT04587908A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD)
NCT00737360Phase II Study of TAS-106 to Treat Head and Neck Cancer
NCT01904253A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
NCT00784290Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma
NCT05691660A Study of TAS3731 in Healthy Adults
NCT00152178The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
NCT01610479A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
NCT04074343TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
NCT00359567Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
NCT04608110A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
NCT04999761AB122 Platform Study
NCT04104139TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer
NCT00229424Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
NCT00152230A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
NCT02752048A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy
NCT02943733Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs